25.84 <%= Resources.Global.txtUp %>
Updated 14/06/2019
Change % 0.72% Stock price increasing
Change 0.185 Stock price increasing
Volume 0
High 25.84
Low 25.84
Open 25.84
ISIN JP3546800008
Prev close 25.66
# of shares 759.52M
Market cap 19,626M EUR
Intraday

Market closed
Terumo Corp
Market is closed, opens at 08:00
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  25.84 1.3% Stock price increasing 5.2% Stock price increasing -6.3% Stock price decreasing 6.7% Stock price increasing -0.7% Stock price decreasing
Powered by TradingView

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Becton Dickinson and Company 234.16 -1.8% Stock price decreasing 3.6% Stock price increasing -7.8% Stock price decreasing 1.2% Stock price increasing 0.9% Stock price increasing 3.9% Stock price increasing
 
Boston Scientific Corporation 40.42 -2.1% Stock price decreasing 7.4% Stock price increasing 0.5% Stock price increasing 12.9% Stock price increasing 22.6% Stock price increasing 14.4% Stock price increasing
 
Johnson & Johnson 140.09 1.1% Stock price increasing 1.4% Stock price increasing 1.8% Stock price increasing 5.3% Stock price increasing 14.3% Stock price increasing 8.6% Stock price increasing
 
Fresenius SE+CO.KGAA O.N. 46.13 0.5% Stock price increasing -5.9% Stock price decreasing -5.8% Stock price decreasing 9.8% Stock price increasing -34.2% Stock price decreasing 8.8% Stock price increasing

Company profile

Terumo Corp manufactures and sells medical products and equipment. The firm has three main businesses: blood management, cardiac and vascular, and general hospital. The cardiac and vascular business generates the largest proportion of revenue and sells cardiac and endovascular interventional therapies, cardiovascular surgical systems, neurovascular products, and vascular graft products. The general hospital business includes diabetes management, consumer healthcare, drug and device technologies, and general hospital products. The blood management business sells blood component, therapeutic apheresis, and cellular technologies. Terumo generates the majority of its revenue in Asia, with Japan contributing the largest proportion of Asian revenue.

Peers

Instruments Last Change  
Becton Dicki.. 234.16 -1.2% Stock price decreasing
Boston Scien.. 40.42 -0.6% Stock price decreasing
Johnson & Jo.. 140.09 -0.4% Stock price decreasing
Fresenius SE.. 46.13 0.0% Stock price decreasing

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
16 June 2019 18:30:00
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190527.1 - EUROWEB5 - 2019-06-16 19:30:00 - 2019-06-16 18:30:00 - 1000 - Website: OKAY